Current Advances in Nanocarriers for Cancer Therapy
Abstract
Nanocarriers have shown optimal therapeutic outcomes through their great potential for encapsulating and effectively delivering bioactive compounds into target cells by navigating a series of intracellular barriers. In this review, drug resistance and cell barriers impeding the drug delivery process have been discussed. Besides, the efficiency of nanocarriers, along with recent advances and novel strategies to overcome drug resistance, increase cell internalization, promote intracellular trafficking, target subcellular locations, and control drug release, has been reviewed. Different types of nanocarriers from the viewpoint of cancer treatment have been introduced, and their prospect as drug delivery vehicles for cancer therapy have been visualized. Hence, this review may contribute to developing nanocarriers for effective and precise drug delivery to a wide range of cells and intracellular targets.
Read the paper
Related studies
- A Coupled SYSTEM of Intracellular Ca 2+ Clocks and Surface Membrane Voltage Clocks Controls the Timekeeping Mechanism of the Heart’s Pacemaker
- A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
- Cancer epigenetics: Moving forward
- Current developments in LC-MS for pharmaceutical analysis
- Myricetin: A comprehensive review on its biological potentials
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.